Bristol-Myers Squibb Company (BMY)
NYSE
Closed
Aug 24, 2026
Day's Range
66.4552 wk Range
42.52Overview - BMY - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
170.86B
P/E (Trailing)
‪14.75‬
P/E (Forward)
‪10.21‬
PEG Ratio
‪0.09‬
Price / Sales (TTM)
‪2.78‬
Price / Book
‪6.13‬
EV / EBITDA
‪9.02‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Short % of Shares Outstanding
‪2.56%‬
Held by Insiders
‪0.09%‬
Held by Institutions
‪84.68%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪60.57‬
200-Day Avg
‪57.14‬
Dividends
Payout Ratio
‪55.29%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 66.21‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BMY - Bristol-Myers Squibb Company
Peers - BMY - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
Profile Summary - BMY - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical company headquartered in Princeton, New Jersey, and founded in 1933. It discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines addressing serious diseases worldwide. The company offers a diverse portfolio including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
